Welcome to Evolent's Q2 2024 earnings conference call. The call discussed rate increases, revenue growth, and margin improvement. Key points included alignment with partners for rate increases and progress towards achieving a $300 million adjusted EBITDA run rate.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing